LivaNova
LIVN

LivaNova (LIVN) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
BarclaysInitiated CoverageOverweight$105.00Oct 7, 2026
Piper SandlerMaintainedOverweight$90.00 from $87.00Sep 2, 2026
NeedhamMaintainedBuy$93.00 from $81.00Aug 5, 2026
MizuhoMaintainedOutperform$95.00 from $90.00Jul 15, 2026
Freedom Capital MarketsInitiated CoverageHold$81.00Jul 1, 2026
KeybancMaintainedOverweight$92.00 from $83.00Jun 22, 2026
BairdMaintainedOutperform$76.00 from $78.00May 7, 2026
MizuhoMaintainedOutperform$90.00 from $85.00May 7, 2026
BarclaysMaintainedEqual-Weight$76.00 from $73.00May 7, 2026
BarclaysMaintainedEqual-Weight$73.00 from $67.00Feb 27, 2026
NeedhamMaintainedBuy$81.00 from $64.00Feb 25, 2026
BarclaysMaintainedEqual-Weight$67.00 from $58.00Jan 9, 2026
StifelMaintainedBuy$70.00 from $65.00Jan 7, 2026
KeybancInitiated CoverageOverweight$81.00Dec 19, 2025
MizuhoMaintainedOutperform$72.00 from $70.00Dec 17, 2025
BairdMaintainedOutperform$70.00 from $63.00Nov 13, 2025
MizuhoMaintainedOutperform$70.00 from $65.00Nov 13, 2025
BairdMaintainedOutperform$63.00 from $61.00Nov 6, 2025
NeedhamMaintainedBuy$64.00Sep 3, 2025
BarclaysMaintainedEqual-Weight$58.00 from $55.00Aug 21, 2025

Frequently asked questions

  • What is the latest analyst rating on LIVN?

    On Oct 7, 2026, Barclays initiated coverage of LivaNova at Overweight with a price target of $105.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.